RECIPHARM PATHWAY TO CLINIC Trademark

Trademark Overview

On Monday, August 28, 2017, a trademark application was filed for RECIPHARM PATHWAY TO CLINIC with the United States Patent and Trademark Office. The USPTO has given the RECIPHARM PATHWAY TO CLINIC trademark a serial number of 79230420. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, October 10, 2025. This trademark is owned by Recipharm AB (publ). The RECIPHARM PATHWAY TO CLINIC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; product research and development; conducting clinical tests and trials for others; technical project management for others relating to all the aforesaid services
recipharm pathway to clinic

General Information

Serial Number79230420
Word MarkRECIPHARM PATHWAY TO CLINIC
Filing DateMonday, August 28, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, October 10, 2025
Registration Number5705937
Registration DateTuesday, March 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2019

Trademark Statements

Goods and ServicesPharmaceutical drug development services; product research and development; conducting clinical tests and trials for others; technical project management for others relating to all the aforesaid services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 10, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRecipharm AB (publ)
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSE
Party NameRecipharm AB (publ)
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSE
Party NameRecipharm AB (publ)
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSE

Trademark Events

Event DateEvent Description
Thursday, April 19, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 20, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, April 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 23, 2018ASSIGNED TO EXAMINER
Monday, April 23, 2018NON-FINAL ACTION WRITTEN
Tuesday, April 24, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 26, 2018NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Friday, April 27, 2018APPLICATION FILING RECEIPT MAILED
Monday, April 30, 2018NON-FINAL ACTION WRITTEN
Tuesday, May 1, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 4, 2018REFUSAL PROCESSED BY MPU
Friday, May 4, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 26, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, June 26, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, July 31, 2019FINAL DISPOSITION PROCESSED
Friday, May 25, 2018REFUSAL PROCESSED BY IB
Friday, October 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 31, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 16, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 26, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 10, 2025CANCELLED SECTION 71

Related Keywords

clinic pathway recipharm services development others technical project relating aforesaid trials management clinical